Insmed (INSM) Debt Ratio (2012 - 2026)
Insmed (INSM) posted Debt Ratio of 0.26 for Q2 2026, down 1.27% on a QoQ basis from 0.26 in Q1 2026, and up 17.94% year-over-year from 0.22 in Q2 2025.
Analysis
Insmed (INSM) Debt Ratio (2012 - 2026) Analysis & Trends
Insmed has reported Debt Ratio for 15 years, with the latest figure at 0.26 in Q2 2026.
- On a quarterly basis, Debt Ratio rose 17.94% year-over-year to 0.26 in Q2 2026; TTM through Jun 2026 was 0.26, a 17.94% increase from a year earlier, with the FY2025 full-year figure at 0.24, down 56.15% from the prior year.
- Debt Ratio was 0.26 for Q2 2026 at Insmed, down from 0.26 in the prior quarter.
- The five-year high for Debt Ratio was 1.21 in Q1 2024, with the low at 0.22 in Q2 2025.
- Average Debt Ratio over 5 years is 0.62, with a median of 0.69 recorded in 2022.
- The sharpest annual moves came in 2024 and 2025: Debt Ratio jumped 58.98% in 2024, then plunged 71.79% in 2025.
- Over 5 years, Debt Ratio stood at 0.68 in 2022, then rose by 27.89% to 0.87 in 2023, then plunged by 37.29% to 0.54 in 2024, then tumbled by 56.15% to 0.24 in 2025, then gained by 8.86% to 0.26 in 2026.
- The last three Debt Ratio figures came in at 0.26 (Q2 2026), 0.26 (Q1 2026), and 0.24 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 0.66 |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 0.58 |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 0.05 |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 0.05 |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | - |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 0.25 |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 0.26 |
| 10 | BioNTech SE | 26.24 Bn | 12.58 Bn | 10.00 Mn | 0.01 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.26 |
| Mar 31, 2026 | 0.26 |
| Dec 31, 2025 | 0.24 |
| Sep 30, 2025 | 0.23 |
| Jun 30, 2025 | 0.22 |
| Mar 31, 2025 | 0.62 |
| Dec 31, 2024 | 0.54 |
| Sep 30, 2024 | 0.47 |
| Jun 30, 2024 | 0.78 |
| Mar 31, 2024 | 1.21 |
| Dec 31, 2023 | 0.87 |
| Sep 30, 2023 | 0.88 |
| Jun 30, 2023 | 0.81 |
| Mar 31, 2023 | 0.76 |
| Dec 31, 2022 | 0.68 |
| Sep 30, 2022 | 0.80 |
| Jun 30, 2022 | 0.76 |
| Mar 31, 2022 | 0.69 |
| Dec 31, 2021 | 0.46 |
| Sep 30, 2021 | 0.61 |